AGM Meeting Clarification

RNS Number:5384O
Arana Therapeutics Limited
22 February 2008



FOR IMMEDIATE RELEASE                                             22 FEBRUARY 2007


                           Arana Therapeutics Limited


                      Annual General Meeting Clarification

            Re-election as a Director not sought by Dr Phil Jennings


Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that Dr Phil Jennings is no longer a Director of
Arana, with effect from the close of the Company's Annual General Meeting held
on 14 February 2008. Dr Jennings' term as Director was scheduled to conclude by
reason of rotation in accordance with clause 6.3 of the Company's Constitution
and, while being eligible for re-election as a Director of the Company, did not
seek re-election as a Director. Dr Jennings continues in his executive role with
the Company as Chief Scientific Officer.



For further information, please contact:

Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer                        [phone]
Niall Henderson, Chief Financial Officer                        [phone]

Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich                            [phone]

Nomura Code Securities
Charles Walker                                                 [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCSEMSAESASEDE